Results

Total Results: 1,758 records

Showing results for "leading".
Users also searched for: pap smear

381. Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
     October 01, 2019 - lower respiratory diseases, of which COPD is the largest contributing condition, are the fourth leading … dyspnea, increased frequency and severity of cough, and/or increased sputum production.6 ECOPD is a leading

382. S77 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s77.pdf
     October 01, 2007 - than the threshold for copayment waiver at the VA (108% of FPL), but below the income and asset level leading

383. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
     September 29, 2010 - children who do have a rheumatic disease such as JIA, serologic tests, especially RF, may be negative, leading

384. S89 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
     October 01, 2007 - ORIGINAL ARTICLE Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse Events Tracy A. Lieu, MD, MPH,*† Martin Kulldorff, PhD,* Robert L. Davis, MD, MPH,‡ Edwin M. Lewis, MPH,§ Eric Weintraub, MPH,‡ Katherine Yih, PhD, MPH,* Ruihua Yin, MS,* Jeffrey S. Brown, PhD,* and Richard Platt, MD, MSc,* for…

385. Disposition of Comments: Technical Brief No. 38_Automated Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-38-chronic-conditions-comments.pdf
     March 01, 2021 - Disposition of Comments: Technical Brief No. 38_Automated Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes Source: https://effectivehealthcare.ahrq.gov/products/health-data-mapping/report Published Online: March 1, 2021 1 Technical Brief Disposition of Comments…

386. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-including-both-children-and-adult-subgroup-comparisons-with-type-1-diabetes-what-is-the-comparitive-differences-in-hba1c-levels-when-comparing-various-treatment-options-including-multiple-daily-injections-insulin
     July 19, 2009 - Home » Get Involved » Nominated Topics » Topic Suggestion Description Topic Suggestion Description Date submitted: July 19, 2009 Download Topic Suggestion Disposition [PDF · 130.2 KB] Briefly describe a specific question, or set of related questions, about a health c…

387. Hesse (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/hesse.pdf
     January 01, 2010 - Hesse Slide 1: Collaborating  for Health: Engaging  Community Intelligence for Better Patient  Outcomes Bradford W. Hesse,  Ph.D. Chief, Health Communication and Informatics Research Branch National Cancer  Institute,  Rockville,  MD Slide 2: Emergence of the…

388. S123 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
     October 01, 2007 - receiving BCSI have lower unmea- sured disease severity than the ESBC patients receiving mastectomy, leading … severity levels between UP and UO in Figure 1 would have received different recommendations from providers leading

389. Ace-Inhibitor-Arb-Update-Surveillance-160328 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update-surveillance-160328.pdf
     March 28, 2016 - $ARB$azilsartan$medoxomil$in$patents$with$systolic$ BP$of$150"180mm$found$that$adverse$events$leading … $ARB$azilsartan$ medoxomil$in$patents$with$systolic$BP$of$150" 180mm$found$that$adverse$events$leading … $Adverse$events$leading$to$discontinuation$were$less$frequent$with$AZL"M$40$and$80mg$(2.4%$and$3.1%,$ … prompted$speculation$that$blockade$of$plasma$renin$activity$with$aliskiren$could$be$ overwhelmed,$leading … $ARB$azilsartan$ medoxomil$in$patents$with$systolic$ BP$of$150"180mm$found$that$ adverse$events$leading

390. Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-cancer-imaging/research-protocol
     December 17, 2013 - Current Page Topic Timeline Dec. 28, 2011 Topic Suggestion Dec. 17, 2013 Research Protocol Oct. 1, 2014 Technical Brief Jan. 29, 2015 Disposition of Comments Report Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer Research Protocol Archived December 17, 2013 Download Main Document PDF 317.6…

391. breast-cancer-imaging-protocol-131217 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_research-protocol.pdf
     December 17, 2013 - breast-cancer-imaging-protocol-131217   Source: www.effectivehealthcare.ahrq.gov Published online: December 17, 2013 1 Evidence-based Practice Center Technical Brief Protocol Project Title: Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer I. Background and Objectives for th…

392. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-risk-bias.ppt
     June 01, 2012 - PowerPoint Presentation Assessing Risk of Bias as a Domain of Quality in Medical Test Studies Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Medical Test Reviews Methods Guide www.ahrq.gov Assessing Risk of Bias as a Domain of Quality in Medical Test Studies This slide set…

393. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-risk-bias.ppt
     June 01, 2012 - PowerPoint Presentation Assessing Risk of Bias as a Domain of Quality in Medical Test Studies Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Medical Test Reviews Methods Guide www.ahrq.gov Assessing Risk of Bias as a Domain of Quality in Medical Test Studies This slide set…

394. Physical Therapy for Knee Pain Secondary to Osteoarthritis Disposition of Comment Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_disposition-comments.pdf
     November 06, 2012 - The key finding that few interventions showed efficacy is a rather negative and uninformative leading … There were interventions that did show efficacy, suggest leading with that. … Physical Therapist Assistants (PTAs) complete an accredited education program leading to an associate

395. Appendicitis Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/appendicitis_research-protocol.pdf
     December 09, 2013 - their discomfort or describing their symptoms, making the clinical examination less informative and leading

396. PCA3 Testing for the Diagnosis and Management of Prostate Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research-protocol
     October 14, 2011 - Current Page Topic Timeline Jul. 29, 2010 Topic Suggestion Oct. 14, 2011 Research Protocol Apr. 1, 2013 Systematic Review Jul. 31, 2013 Disposition of Comments Report PCA3 Testing for the Diagnosis and Management of Prostate Cancer Research Protocol Archived October 14, 2011 Download Main Document PDF 473.2 KB …

397. Disposition of Comments Report for Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
     July 08, 2014 - Disposition of Comments Report for Treatment of Depression During Pregnancy and the Postpartum Period Evidence Report/Technology Assessment Disposition of Comments Report Research Review Title: Treatment of Depression During Pregnancy and the Postpartum Period Draft review available for public comment f…

398. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
     September 01, 2014 - Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Combination Therapy Versus Intensification of Statin Monotherapy: An Update. Draft revi…

399. Methods Future Research Needs Number 8: Framework for Considering Study Designs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
     March 01, 2012 - Problems are often identified with the amount or quality of the literature examined, leading to an … time, the RCTs of some questions (particularly long-term outcomes) may be vulnerable to crossover, leading … clinical visit, may be susceptible to ‗gaming.‘ When study duration is long, crossover may occur, leading … Other co-interventions may occur in the health care environment, leading to difficulties in attribution

400. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
     June 22, 2017 - Major bleeding is defined as: fatal bleeding, bleeding leading to transfusion, major bleeding leading … to reoperation, major bleeding leading to readmission, surgical site/joint bleeding, bleeding leading